MediPal Holdings Corporation
7459
Κατάταξη σε μετοχές
#4252
Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898,... Medipal Holdings Corporation, a Tokyo, Japan-based company founded in 1898, primarily specializes in the wholesale distribution of prescription pharmaceuticals throughout Japan. The firm procures a broad spectrum of healthcare products, including medical equipment, materials, and clinical diagnostic reagents, utilized across diagnostics, testing, treatment, and administration, often from the pre-symptomatic stage. It also offers contract-based post-marketing surveillance (PMS) services to manufacturers and strategically invests in products like orphan drugs. Beyond pharmaceuticals, Medipal Holdings diversifies its wholesale activities to encompass cosmetics, daily necessities, and over-the-counter medications. Its extensive product portfolio further includes animal health products for companion animals, raw materials for food processing in the agricultural, fisheries, and livestock sectors, along with livestock feed additives, various seasonings, veterinary medical equipment, packaging materials, and industrial chemicals. The company also provides a comprehensive suite of specialized services. These include conducting contract epidemiological and clinical studies, creating computerized databases for medical supplies and master product data for healthcare facilities, and offering health insurance claims reviews, medical coding dispatch, outsourcing, and remote education. Medipal's operations extend to life and non-life insurance agency services, cleaning management, the full management and operation of distribution centers, commissioned delivery, and worker dispatch. Additionally, it handles the planning, management, administration, and product/service development for its branded Class A health dispensing pharmacies. Serving an expansive client base, Medipal Holdings partners with hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company adopted its current name, Medipal Holdings Corporation in October 2009, having previously operated as Mediceo Paltac Holdings Co., Ltd.
Τιμή μετοχής
$20.55
Κεφαλαιοποίηση
$3.73B
Αλλαγή (1 ημέρα)
0.77%
Αλλαγή (1 έτος)
22.26%
Χώρα
JP
Εμπόριο MediPal Holdings Corporation (7459)
Κατηγορία
Healthcare
Λειτουργικό Περιθώριο για MediPal Holdings Corporation (7459)
Λειτουργικό Περιθώριο στις October 2026 TTM: 1.36%
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της MediPal Holdings Corporation, το τρέχον Λειτουργικό Περιθώριο (TTM) είναι 1.36%. Στο τέλος του 2024, το Λειτουργικό Περιθώριο ήταν 1.33%.
Ιστορικό Λειτουργικού Περιθωρίου για την MediPal Holdings Corporation από 2005 έως 2026
Λειτουργικό Περιθώριο στο τέλος κάθε έτους
| Έτος | Λειτουργικό Περιθώριο | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 1.36% | -9.93% |
| 2025 | 1.51% | 13.53% |
| 2024 | 1.33% | -8.90% |
| 2023 | 1.46% | 5.04% |
| 2022 | 1.39% | 15.83% |
| 2021 | 1.20% | -26.38% |
| 2020 | 1.63% | 3.82% |
| 2019 | 1.57% | 11.35% |
| 2018 | 1.41% | 9.30% |
| 2017 | 1.29% | -7.86% |
| 2016 | 1.40% | 22.81% |
| 2015 | 1.14% | -3.39% |
| 2014 | 1.18% | 16.83% |
| 2013 | 1.01% | 32.89% |
| 2012 | 0.76% | 49.02% |
| 2011 | 0.51% | -29.17% |
| 2010 | 0.72% | 30.91% |
| 2009 | 0.55% | -55.65% |
| 2008 | 1.24% | -3.13% |
| 2007 | 1.28% | 19.63% |
| 2006 | 1.07% | 62.12% |
| 2005 | 0.66% | 0.00% |
Λειτουργικό Περιθώριο για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Λειτουργικό Περιθώριο | Διαφορά Λειτουργικού Περιθωρίου | Χώρα |
|---|---|---|---|
| 1.62% | -98.81% |
US
|
|
| 0.00% | - |
US
|
|
| 1.03% | -99.24% |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -93.23% |
AU
|
Τι είναι το Λειτουργικό Περιθώριο μιας εταιρείας;
Το Λειτουργικό Περιθώριο είναι ένας βασικός δείκτης για την αξιολόγηση της κερδοφορίας μιας εταιρείας. Όσο υψηλότερο είναι το Operating Margin, τόσο το καλύτερο, καθώς δείχνει ότι η εταιρεία πωλεί τα προϊόντα ή τις υπηρεσίες της με σημαντικό περιθώριο κέρδους. Υπολογίζεται διαιρώντας τα κέρδη της εταιρείας με τα έσοδά της.